<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE STATEMENT OF OPERATIONS AND BALANCE SHEET OF ALLERGAN SPECIALTY THERAPEUTICS, INC. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> JAN-01-1998 <PERIOD-END> DEC-31-1998 <CASH> 0 <SECURITIES> 158,667 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 158,667 <PP&E> 0 <DEPRECIATION> 0 <TOTAL-ASSETS> 165,137 <CURRENT-LIABILITIES> 4,804 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 34 <OTHER-SE> 160,299 <TOTAL-LIABILITY-AND-EQUITY> 165,137 <SALES> 0 <TOTAL-REVENUES> 9,043 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 43,339 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (34,296) <INCOME-TAX> 2,512 <INCOME-CONTINUING> (36,808) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (36,808) <EPS-PRIMARY> $(11.24) <EPS-DILUTED> $(11.24)